Follow The Filings

SRZN Surrozen

Surrozen earnings company data as of 7:50 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by SRZN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SRZN insider trades
  • $16.8M bought by 3 insiders
  • $6.9M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. TCG Crossover GP II, LLC 10% owner, +4 joint filers
    Sale
    $6.9M 325,000 shares at $21.25 36% of stake
    Traded Jul 22 Filed Jul 24
  2. TCG Crossover GP II, LLC 10% owner, +3 joint filers
    Buy
    $3M 121,881 shares at $24.72 +20% to stake
    Traded Mar 23–24 Filed Mar 25
  3. TCG Crossover GP II, LLC 10% owner, +3 joint filers
    Buy
    $1.2M 48,997 shares at $24.91 +7.8% to stake
    Traded Mar 12–16 Filed Mar 16
  4. TCG Crossover GP II, LLC 10% owner, +3 joint filers
    Buy
    $445K 18,856 shares at $23.59 +3% to stake
    Traded Feb 11–12 Filed Feb 13
  5. TCG Crossover GP II, LLC 10% owner, +3 joint filers
    Buy
    $203K 9,357 shares at $21.65 +1.5% to stake
    Traded Jan 30–Feb 3 Filed Feb 3
  6. Column Group Iii Gp, LP 10% owner, +6 joint filers
    Buy
    $642K 32,507 shares at $19.74 +3.3% to stake
    Traded Jan 15–20 Filed Jan 20
  7. Tim Kutzkey Director
    Buy
    $357K 17,993 shares at $19.86 +1.8% to stake
    Traded Jan 13–14 Filed Jan 15
  8. Column Group Iii Gp, LP 10% owner, +6 joint filers
    Buy
    $300K 15,100 shares at $19.89 +1.5% to stake
    Traded Jan 6 Filed Jan 8
  9. Tim Kutzkey Director
    Buy
    $695K 36,150 shares at $19.22 +3.8% to stake
    Traded Dec 4–5 Filed Dec 8, 2025
  10. Tim Kutzkey Director
    Buy
    $4M 315,457 shares at $12.65 +49% to stake
    Traded Nov 13, 2025 Filed Dec 2, 2025

Also filed in the last 12 months, not counted as buying or selling: 11 option exercises, 7 stock grants, 5 sales to cover taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13D/A —
8-K 2.02,3.02,9.01
SCHEDULE 13G/A —
8-K 8.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02
10-Q
SCHEDULE 13G/A —
SCHEDULE 13D/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.07
8-K 2.02,9.01
10-Q
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.